27
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

The Optimal Treatment of Carotid Atherosclerosis: A 2008 Update and Literature Review

, DO, , MD, MPH, , MD, , MD, , MD & , MD, FACC, FAHA, FSCAI, FESC
Pages 103-112 | Published online: 30 Jun 2015

References

  • Bhatt DL, Steg PG, Ohman EM, et al. REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006; 295(2): 180–189.
  • Steg PG, Bhatt DL, Wilson PW, et al. REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007; 297(11): 1197–1206.
  • American College of Cardiology Foundation; American Society of Interventional and Therapeutic Neuroradiology; Society for Cardiovascular Angiography and Interventions, et al; Bates ER, Babb JD, Casey DE Jr, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/ SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol. 2007; 49(1): 126–170.
  • Thom T, Haase N, Rosamond W, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113(6): e85-el51.
  • Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991; 325(7): 445–453.
  • Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351(9113): 1379–1387.
  • Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991; 266(23): 3289–3294.
  • Rothwell PM, Eliasziw M, Gutnikov SA, et al. Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003; 361 (9352): 107–116.
  • Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995; 273(18): 1421–1428.
  • Mohammed N, Anand SS. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. MRC asymptomatic carotid surgery trial (ACST) collaborative group. Lancet. 2004; 363: 1491–1502. Vase Med. 2005; 10(1): 77–78.
  • Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA. 1998; 279(16): 1278–1281.
  • Tu JV, Hannan EL, Anderson GM, et al. The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med. 1998; 339(20): 1441–1447.
  • Yadav JS, Iyer S, Vitek J, et al. Elective stenting of the extracranial carotid arteries. Circulation. 1997; 95(2): 376–381.
  • Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001; 357(9270): 1729–1737.
  • Wholey MH, Al-Mubarek N. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Jnterv. 2003; 60(2): 259–266.
  • Bhatt DL, Kapadia SR, Bajzer CT, et al. Dual antiplatelet therapy with Clopidogrel and aspirin after carotid artery stenting. J Invasive Cardiol. 2001; 13(12): 767–771.
  • Chen MS, Bhatt DL, Mukherjee D, et al. Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv. 2004; 61(4): 437–442.
  • Orlandi G, Gallerini S, Cosottini M, Murri L. Postprocedural emboli in carotid artery stenting: where do they come from? Stroke. 2005; 36(5): 928; author reply 928–929.
  • Cosottini M, Michelassi MC, Puglioli M, et al. Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. Stroke. 2005; 36(11): 2389–2393.
  • Aronow HD, Yadav JS. Embolic protection for carotid artery stenting—a ‘no brainer’. Acta Chir Belg. 2004; 104(1): 65–70.
  • Cho L, Yadav JS. Embolization in atherosclerosis. Neuroimaging Clin N Am. 2002; 12(3): 365–372.
  • Yadav JS. Embolic protection devices: methods, techniques, and data. Tech Vase Interv Radiol. 2004; 7(4): 190–193.
  • Chan AW, Yadav JS, Bhatt DL, et al. Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. Am J Cardiol. 2005; 95(6): 791–795.
  • Bhatt DL. Emboli protection devices. J Invasive Cardiol. 2004; 16(suppl): 45S-49S.
  • Whitlow P. SECURITY: Multicenter evaluation of carotid stenting with a distal protection filter. Paper presented at: Transcatheter Cardiovascular Therapeutics; September 15–19, 2003; Washington, DC.
  • Reimers B, Sievert H, Schuler GC, et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther. 2005; 12(2): 156–165.
  • Kastrup A, Groschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke. 2003; 34(3): 813–819.
  • Mas JL, Chatellier G, Beyssen B. EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke. 2004; 35(1): e18–e20.
  • Yen MH, Lee DS, Kapadia S, et al. Symptomatic patients have similar outcomes compared with asymptomatic patients after carotid artery stenting with emboli protection. Am J Cardiol. 2005; 95(2): 297–300.
  • Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004; 3 51 (15). 1493–1501.
  • Gurm HS, Yadav JS, Fayad P, et al. SAPPHIRE Investigators. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008; 358(15): 1572–1579.
  • Cambria R. Stenting for carotid-artery stenosis. N Engl J Med. 2004; 351(15): 1565–1567.
  • Kertai MD, Boersma E, Klein J, Van Urk H, Bax JJ, Poldermans D. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur J Vase Endovasc Surg. 2004; 28(1): 59–66.
  • Schreiber T, Cohen S, Massop D, et al. First Report of the CASES-PMS Study: Patient Demographics and 30-Day Major Adverse Events for the Cordis PRECISE Nitinol Stent and Angioguard XP Emboli Capture Guidewire Condition of Approval Surveillance Study. Paper presented at: American College of Cardiology, 2006; Atlanta, GA.
  • Safian RD, Bresnahan JF, Jaff MR, et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol. 2006; 47(12): 2384–2389.
  • Scherer R. Performance And Safety of the Medtronic AVE Self-Expandable Stent in the Treatment of Carotid Artery Lesions (PASCAL). http://www.strokecenter.org/trials/TrialDetail.aspx?tid=282. Accessed July 10, 2007.
  • Coppi G, Moratto R, Silingardi R, et al. PRIAMUS—Proximal flow blockage cerebral protection during carotid stenting: results from a multicenter Italian registry. J Cardiovasc Surg (Torino). 2005; 46(3): 219–227.
  • Leon MB. Rubicon filter in carotids (rule-cartoids). http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=803263. Accessed July 10, 2007.
  • Bard C. The ViVEXX Carotid Revascularization Trial (VIVA) for high surgical risk patients with extracranial carotid artery stenosis using the Bard ViVEXX carotid stent and Emboshield® BareWire Rapid Exchange Embolic Protection System. http://www.clinicaltrials.gov/ct/show/NCT00417963?ordei=2. Accessed July 10, 2007.
  • White C. Boston Scientific EPI-A Carotid Stenting Trial for High Risk Surgical Patients (BEACH)-1 year results. Paper presented at: 14th Annual Peripheral Angioplasty and All That Jazz; April 27,2005; New Orleans, LA.
  • Stroke Interventions in Clinical Trials: Multicenter randomized trials comparing carotid endarterectomy with stent placement ongoing, http://www.strokecenter.org/trials/InterventionDetail.aspx?tid=98. Accessed July 10, 2007.
  • Schwarten D. Emboshield® and Xact® Post-Approval Carotid Stent Trial (The EXACT Study), http://www.clinicaltrials.gov/ct/show/NCT00287508?order=l. Accessed July 10, 2007.
  • CAPTURE Investigators. Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events (CAPTURE 2). http://www.clinicaltrials.gov/ct/show/NCT00302237?order=27. Accessed July 10, 2007.
  • Theiss W, Hermanek P, Mathias K, et al. German Societies of Angiology and Radiology. Pro-C AS: a prospective registry of carotid angioplasty and stenting. Stroke. 2004; 35(9): 2134–2139.
  • White CJ, Iyer SS, Hopkins LN, Katzen BT, Russell ME; BEACH Trial Investigators. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv. 2006; 67(4): 503–512.
  • CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vase Surg. 2005; 42(2): 213–219.
  • Schofer J. Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting: EPIC European Study, http://www.clinicaltrials.gov/ct/show/NCT00309803?order=9. Accessed July 10, 2007.
  • Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv. 2007; 69(3): 341–348.
  • Ramee S. MAVErIC I and II Trials: Evaluation of the Medtronic AVE Self-Expanding Carotid Stent System in the Treatment of Carotid Stenosis. Transcatheter Cardiovascular Therapeutics 2004. Washington, DC; 2004.
  • Scherer R. Medtronic Launches 3rd Phase Of Carotid Stenting Trial. Evaluation of the Medtronic AVE Self-Expanding Carotid Stent System in the Treatment of Carotid Stenosis (MAVErlC)-III [press release], http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=l100708577210&lang=en_US. Accessed July 10, 2007.
  • Iyer SS, White CJ, Hopkins LN, et al. Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. J Am Coll Cardiol. 2008; 51(4): 427–434.
  • Iyer S. Stenting of High risk patients Extracranial Lesions Trial with Emboli Removal (SHELTER). http://www.strokecenter.org/Trials/TrialDetail.aspx?tid=192. Accessed July 10, 2007.
  • Myla S. The NexStent® Carotid Stent System: A Post Market Approval Evaluation Study in Conjunction with the FilterWire EZTM Embolic Protection System. http://www.clinicaltrials.gov/ct2/show/NCT00478673. Accessed April 1, 2008.
  • SAPPHIRE Worldwide. Stenting and Angioplasty With Protection in Patients At High Risk for Endarterectomy. http://clinicaltrials.gov/ct2/show/NCT00403078?term=SAPPHIRE+Worldwide&rank=1. Accessed April 1,2008.
  • Rosenfield K. Asymptomatic Cartoid Stenosis, Stenting Versus Endartectomy Trial (ACT I), http://www.strokecenter.org/trials/TrialDetail.aspx?tid=624. Accessed July 10, 2007.
  • Brown MM. International Carotid Stenting Study (1CSS/CAVATAS-2). http://www.strokecenter.org/trials/browse.aspx71etterf. Accessed July 10, 2007.
  • Hobson RW II. Carotid Revascularization Endartectomy Versus Stenting Trial (CREST). http://www.clinicaltrials.gov/ct2/show/NCT00004732?term=Carotid+Revascularization+endarterectomy+Versus+Stenting+Trial&rank=1. Accessed July 10, 2007.
  • Mas J, Chatellier G, Beyssen B, et al. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 355(16): 1660–1671.
  • SPACE Collaborative Group, Ringleb PA, Allenberg J, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non- inferiority trial. Lancet. 2006; 368(9543): 1239–1247.
  • Gaines P, Randall M. Carotid artery stenting for patients with asymptomatic carotid disease (and news on TACIT). Eur J Vase Endovasc Surg. 2005; 30(5): 461–463.
  • Alberts MJ. Results of a multicenter prospective randomized trial of carotid artery stenting vs carotid endartectomy. Stroke. 2001; 32: 325d.
  • Harjai KJ, Mehta RH. Trials and tribulations of carotid artery stenting: The Interventionalists' perspective on SAPPHIRE, EVA-3S, and SPACE Trials. J Interv Cardiol. 2007; 20(5): 389–394.
  • Schillinger M. Stenting Versus Best Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis. http://clinicaltrials.gov/ct/show/NCT00497094. Accessed July 10, 2007.
  • Eagle KA, Guyton RA, Davidoff R, et al. American College of Cardiology; American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004; 110(14): e340-e437.
  • Ziada KM, Yadav JS, Mukherjee D, et al. Comparison, of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol. 2005; 96(4): 519–523.
  • Centers for Medicare and Medicaid Services. Medicare expands coverage of carotid artery stenting for patients at high risk for surgery [press release], http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1391. Accessed July 10, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.